Chesnara Plc: Fourth acquisition in two years
12 November 2026
Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotechnology company headquartered in South San Francisco, is making waves in the healthcare sector with its innovative approach to treating..
Bioventus Inc. (NASDAQ: BVS), a prominent name in the healthcare sector, specializes in medical devices aimed at pain relief and musculoskeletal therapies. Headquartered in Durham, North..
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) operates at the intersection of biotechnology and healthcare, providing key products that facilitate the development of drug therapies, vaccines, and..
Verve Therapeutics, Inc. (NASDAQ: VERV) has been making waves within the biotechnology industry, offering investors a thrilling opportunity with a potential upside of 324.67%, according to..
Standard BioTools Inc. (NASDAQ: LAB) is capturing investor attention with its significant potential upside, pegged at 138.96%. As a key player in the medical devices sector,..
Humacyte, Inc. (NASDAQ: HUMA), a pioneering entity in the biotechnology sector, is capturing the attention of investors with its innovative approach to developing bioengineered human tissues...
For investors with a penchant for high-risk, high-reward opportunities, MeiraGTx Holdings plc (NASDAQ: MGTX) presents an intriguing case. This clinical-stage gene therapy company, focused on treating..
Oruka Therapeutics, Inc. (NASDAQ: ORKA) is making waves in the biotechnology sector with its promising therapeutic developments and compelling stock potential. As a clinical-stage biopharmaceutical company,..
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) is drawing significant attention from investors eager to tap into the potential upside of 91.63% suggested by its current average analyst..
Castle Biosciences, Inc. (NASDAQ: CSTL), a prominent player in the healthcare sector focusing on molecular diagnostics, is capturing significant attention from investors seeking substantial growth opportunities...
HealthStream, Inc. (NASDAQ: HSTM) stands as a notable player in the health information services industry, delivering essential Software-as-a-Service (SaaS) solutions to healthcare organizations across the United..
Opthea Limited (ASX: OPT), an Australian biotechnology company, is making waves in the healthcare sector with its pioneering approach to treating eye diseases. As a clinical-stage..
Enliven Therapeutics, Inc. (ELVN), a burgeoning name in the biotechnology industry, presents a compelling opportunity for investors seeking exposure to the healthcare sector. With a market..
Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is making waves in the biotechnology sector, presenting a compelling opportunity for investors seeking exposure to cutting-edge cancer therapies. With a..
Stoke Therapeutics, Inc. (NASDAQ: STOK) is drawing significant attention in the biotechnology sector, thanks to its innovative approach to treating severe genetic diseases. With a market..
Fortrea Holdings Inc. (NASDAQ: FTRE), a relatively new player in the healthcare sector, is capturing the attention of investors with its intriguing mix of challenges and..
Trevi Therapeutics, Inc. (NASDAQ: TRVI), a clinical-stage biopharmaceutical company, has been capturing the attention of investors with its promising pipeline and significant upside potential. Specializing in..
For investors seeking opportunities in the biotechnology sector, Zenas BioPharma, Inc. (NASDAQ: ZBIO) presents an intriguing proposition. With its focus on transformative immunology-based therapies, Zenas BioPharma..
InnovAge Holding Corp. (NASDAQ: INNV), a key player in the healthcare sector, operates within the medical care facilities industry. The company specializes in providing comprehensive medical..
Precigen, Inc. (NASDAQ: PGEN), a cutting-edge player in the biotechnology sector, is capturing attention with its promising technologies and staggering potential upside. With a market cap..
